Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand

Abstract Background Hand, foot and mouth disease (HFMD) is endemic among population of young children in Thailand. The disease is mostly caused by enterovirus 71 (EV71) and coxsackievirus A16 (CA16). Methods This study conducted serosurveillance for neutralizing (NT) antibodies to EV71 subgenotypes...

Full description

Bibliographic Details
Published in:	Virology Journal
Main Authors:	Hatairat Lerdsamran, Jarunee Prasertsopon, Anek Mungaomklang, Chompunuch Klinmalai, Pirom Noisumdaeng, Kantima Sangsiriwut, Boonrat Tassaneetrithep, Ratigorn Guntapong, Sopon Iamsirithaworn, Pilaipan Puthavathana
Format:	Article
Language:	English
Published:	BMC 2018-10-01
Subjects:	Hand foot and mouth disease Enterovirus 71 Coxsackievirus A16 Seroprevalence
Online Access:	http://link.springer.com/article/10.1186/s12985-018-1074-8

Similar Items

Longitudinal study on enterovirus A71 and coxsackievirus A16 genotype/subgenotype replacements in hand, foot and mouth disease patients in Thailand, 2000–2017
by: Pirom Noisumdaeng, et al.
Published: (2019-03-01)

Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade
by: Pirom Noisumdaeng, et al.
Published: (2018-12-01)

Molecular evolutionary dynamics of enterovirus A71, coxsackievirus A16 and coxsackievirus A6 causing hand, foot and mouth disease in Thailand, 2000–2022
by: Pirom Noisumdaeng, et al.
Published: (2023-10-01)

Antiviral effect in association with anti-apoptosis and anti-autophagy of repurposing formoterol fumarate dihydrate on enterovirus A71-infected neuronal cells
by: Kachaporn Jintana, et al.
Published: (2022-04-01)

Measuring SARS-CoV-2 RNA in Bangkok wastewater treatment plants and estimating infected population after fully opening the country in 2023, Thailand
by: Thanchira Saita, et al.
Published: (2025-03-01)

T cell mediated immunity against influenza H5N1 nucleoprotein, matrix and hemagglutinin derived epitopes in H5N1 survivors and non-H5N1 subjects
by: Pirom Noisumdaeng, et al.
Published: (2021-03-01)

Molecular characterization and geographical distribution of Zika virus worldwide from 1947 to 2022
by: Pirom Noisumdaeng, et al.
Published: (2023-11-01)

A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
by: Jutatip Panaampon, et al.
Published: (2012-01-01)

Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients
by: Hatairat Lerdsamran, et al.
Published: (2024-01-01)

Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves.
by: Hatairat Lerdsamran, et al.
Published: (2022-01-01)

Coxsackieviruses B1–6 as Etiological Factor of Enterovirus Infection
by: N. I. Romanenkova, et al.
Published: (2016-07-01)

High plasma levels of soluble tumor necrosis factor receptor type II (sTNFRII) but low plasma levels of soluble FasL (sFasL) in patients with severe pandemic H1N1 2009 influenza infectio
by: Chintana Phawong, et al.
Published: (2015-05-01)

Serostatus of echovirus 11, coxsackievirus B3 and enterovirus D68 in cord blood: The implication of severe newborn enterovirus infection
by: Ya-Li Hu, et al.
Published: (2023-08-01)

Enterovirus genotype diversity with emergence of coxsackievirus A2 circulating in pediatric patients with acute gastroenteritis in Thailand, 2019–2022
by: Zhenfeng Xie, et al.
Published: (2024-06-01)

Global landscape of coxsackieviruses in human health
by: Raiana S. Machado, et al.
Published: (2024-06-01)

Antiviral activity of a crude extract of Thalassia testudinum Banks ex König against the human enteroviruses echovirus 9 and coxsackievirus A16
by: Liena de R. Ponce Rey, et al.
Published: (2025-09-01)

Infectious Entry Pathway of Enterovirus B Species
by: Varpu Marjomäki, et al.
Published: (2015-12-01)

Antiviral Effects of Menthol on Coxsackievirus B
by: David J.R. Taylor, et al.
Published: (2020-03-01)

Clinical and Genomic Epidemiology of Coxsackievirus A21 and Enterovirus D68 in Homeless Shelters, King County, Washington, USA, 2019–2021
by: Sarah N. Cox, et al.
Published: (2024-11-01)

Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys
by: Ting Yang, et al.
Published: (2020-07-01)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China
by: Ji Hong, et al.
Published: (2012-10-01)

Molecular Epidemiology and Evolution of Coxsackievirus A14
by: Liheng Yu, et al.
Published: (2023-11-01)

Human Antibodies to VP4 Inhibit Replication of Enteroviruses Across Subgenotypes and Serotypes, and Enhance Host Innate Immunity
by: Siratcha Phanthong, et al.
Published: (2020-09-01)

Antiviral Mechanisms of Saucerneol from <i>Saururus chinensis</i> against Enterovirus A71, Coxsackievirus A16, and Coxsackievirus B3: Role of Mitochondrial ROS and the STING/TKB-1/IRF3 Pathway
by: Jae-Hyoung Song, et al.
Published: (2023-12-01)

Detection and identification of coxsackievirus B3 from sera of an Indonesian patient with undifferentiated febrile illness
by: Ageng Wiyatno, et al.
Published: (2016-08-01)

Computational Screening of Newly Designed Compounds against Coxsackievirus A16 and Enterovirus A71
by: Amita Sripattaraphan, et al.
Published: (2022-03-01)

Polyamine Analog Diethylnorspermidine Restricts Coxsackievirus B3 and Is Overcome by 2A Protease Mutation In Vitro
by: Bridget M. Hulsebosch, et al.
Published: (2021-02-01)

Characterization of Coxsackievirus A6- and Enterovirus 71-associated Hand Foot and Mouth disease in Beijing, China, from 2013 to 2015
by: Jie eLi, et al.
Published: (2016-03-01)

Atypical presentation of Hand foot mouth disease (HFMD) caused by enterovirus serotype Coxsackievirus A6, in India
by: Muruganandam Nagarajan, et al.
Published: (2019-08-01)

Molecular Epidemiology and Evolution of Coxsackievirus A9
by: Hehe Zhao, et al.
Published: (2022-04-01)

Serology supportive of recent coxsackievirus B infection is correlated with multisystem inflammatory syndrome in children (MIS-C)
by: Ramesh Kordi, et al.
Published: (2025-03-01)

Coxsackievirus B3 Activates Macrophages Independently of CAR-Mediated Viral Entry
by: Yasir Mohamud, et al.
Published: (2024-09-01)

Rhombencephalitis and Coxsackievirus A16
by: Kazuna Goto, et al.
Published: (2009-10-01)

Conjuntivite hemorrágica aguda causada pela variante do coxsackievirus A24, em Belém, Pará, Brasil, 1987
by: Elisabeth de O. Santos, et al.
Published: (1989-06-01)

Actividad antiviral del alga "Sargassum fluitans" (Børgesen) Børgesen 1914, frente al echovirus 9, el coxsackievirus A16 y el coxsackievirus A24
by: Liena de Regla Ponce Rey, et al.
Published: (2021-07-01)

Rare occurrence of Coxsackievirus B4 along with Coxsackieviruses A6 and A10 from hand, foot and mouth disease
by: Sampada Tambolkar, et al.
Published: (2023-07-01)

Seasonal Testing, Results, and Effect of the Pandemic on Coxsackievirus Serum Studies
by: Ramesh Kordi, et al.
Published: (2024-02-01)

Coxsackievirus A24 causing acute conjunctivitis in a 2023 outbreak in Vietnam
by: Huy Tran, et al.
Published: (2024-09-01)

Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71
by: Xiu Hui Tan, et al.
Published: (2023-08-01)

Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study
by: Chonnamet Techasaensiri, et al.
Published: (2021-05-01)